Cellid, a developer of virus vector Covid-19 vaccine candidate, AdCLD-CoV19-1, said it has joined the COVAX Marketplace that allocates raw materials for vaccines.The innovative market coordinated by COVAX provides suppliers with a platform to allocate or reallocate unused materials for vaccines, mob
The government said that it would donate 1.57 million Covid-19 vaccines to Vietnam and Thailand to help countries having difficulties securing vaccines and immunizing overseas Koreans.This is the first time that Korea has decided to supply its secured vaccines to foreign countries directly."We have
Genencell said Tuesday that it asked the Ministry of Food and Drug Safety to authorize phase 2 and 3 clinical trials of ES16001, the company’s oral Covid-19 therapy. The company expects the domestic study to serve as a starting point for its global clinical trials of ES16001 in European countries.ES
Celltrion said that it has completed the approval application procedure for CT-P16, a biosimilar of Avastin (ingredient: bevacizumab), to the European Medicines Agency (EMA)."We submitted the application after completing global clinical trials for a total of 689 patients at 164 sites in 21 countries
Pharmaceutical companies are actively working with drug delivery systems (DDS) companies to develop long-acting injections.Long-acting injections are drawing much attention because they are regarded as a new “growth engine” that can overcome the shortcomings of existing treatments.The development of
EuBiologics, developing a home-grown Covid-19 vaccine, said it would apply for a local phase 3 study of its vaccine candidate in several days.The company said it would also apply for a global phase 3 trial of EuCorVac-19 to the Ministry of Food and Drug Safety within this week.EuBiologics plans to u
SK Bioscience said its Covid-19 vaccine candidate GBP510 has recently received approval from the Vietnamese government to run phase 3 clinical trials, speeding up the development through global studies in five countries.The International Vaccine Institute (IVI), collaborating with SK Bioscience for
LegoChem Bioscience said it has entered into a research collaboration and license option agreement to develop an antibody-drug conjugate (ADC) treatment with a Chinese biopharmaceutical firm.However, the company did not name which Chinese company, citing a contractual term.Under the accord, the two
A study conducted by MD Anderson Cancer Center, U.S., has confirmed that poziotinib can further improve the kirsten rat sarcoma virus (KRAS) inhibitory activity when administered combined with an agent inhibiting KRAS."Spectrum, a partner of Hanmi, announced that the results of the poziotinib combin
The Ministry of Food and Drug Safety (MFDS) opened the possibility of granting an exemption of a bridging trial of Mifegymiso, an abortion drug that the regulator is reviewing for marketing approval.Researchers can obtain data for Koreans through a bridging trial when it is difficult to apply foreig
Director of Myongji Hospital’s Dementia Care Center and Brain BankThe government began selecting a dementia brain bank in 2016, and it picked Myongji Hospital as the nation’s fourth hospital to run a dementia brain bank in March 2021.The other three hospitals operating a government-designated dement
Domestic pharmaceutical companies are speeding up efforts to develop chimeric antigen receptor T (CAR-T) cell therapy after the government approved the first gene editing CAR-T treatment, Kymriah, this year, industry watchers said Thursday.Drugmakers are competing to develop the patient-tailored tre
Encouraged by investors' growing interests in the biopharmaceutical industry amid the prolonged Covid-19 pandemic, local drugmakers are going all out to secure financial resources through massive bond issuance, market watchers said Thursday.Their moves aim to invest in new businesses and strengthen
The government has decided to expand home treatments for Covid-19 patients as a measure to prepare for gradually switching the nation’s infection control to return to the “live-with-covid” system early next month.The number of Covid-19 patients to treat symptoms at home has been significantly expand
Korean consumers are increasingly purchasing fever reducers they prefer, as the nation’s Covid-19 vaccination rate is picking up.According to the Korea Disease Control and Prevention Agency, over 64.5 percent of the Korean population aged 18 or more have completed receiving the full doses of Covid-1
Naver, the nation’s largest internet portal, is seeking to enter the digital healthcare market.Industry officials said that its success would hinge on how the company could use its powerful IT technologies and AI platforms in the healthcare field.Rha Koon-ho, head of Naver’s Healthcare Research Inst
Samsung Biologics has signed an agreement with Texas-based biotech company Enzolytics for developing and manufacturing monoclonal antibody therapy for Covid-19.Under the accord, Samsung Biologics will provide an end-to-end service to develop cell lines, manufacture clinical trial material, and apply
The 2021 International Congress of Diabetes and Metabolism (ICDM) kicked off its three-day online conference on Thursday. Sponsored by the Korean Diabetes Association (KDA), ICDM celebrates its 11th anniversary of discussing diabetes and endocrine systems.Notably, the conference put a lot of its foc
Korean AI-using drug developers are establishing overseas branches or a wet lab to seek new business opportunities.In Korea, various AI-backed drug discovery companies have emerged to find new medicines. They include Standigm, Syntekabio, Deargen, Oncocross, Pharos iBio, Baobab AiBIO, PharmCADD, and
Biogen Korea said it would begin global phase 3 ASCEND trials of high-dose nusinersen, marketed as Spinraza, in treating patients with late-onset spinal muscular atrophy (SMA) who received Roche’s risdiplam in the past.It will conduct the second part of the ASCEND study for 2.5 years with 135 SMA pa